aflibercept (AVE0005)
Sponsors
Sanofi
Conditions
CancerNeoplasm MalignantNeoplasms
Phase 1
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
CompletedNCT00479076
Start: 2007-03-31End: 2011-01-31Target: 22Updated: 2011-01-26
A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients
CompletedNCT00545246
Start: 2007-10-31End: 2012-07-31Updated: 2013-10-16
A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients
CompletedNCT00876044
Start: 2009-04-30End: 2010-11-30Updated: 2016-05-05
A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors
CompletedNCT01148615
Start: 2010-07-31End: 2011-12-31Updated: 2012-01-13